All Market Participants are hereby informed that Novartis India Limited (the “Company”), has announced cash offer to buyback not exceeding 34,50,000 (Thirty Four Lakhs And Fifty Thousand) fully paid-up equity shares of face value Rs 5/- each, representing 12.26% of the total number of equity shares in the present issued, subscribed and paid-up equity share capital of the company, from all the existing shareholders / beneficial owners of equity shares of the Company as on the record date i.e. Friday, December 8, 2017, on a proportionate basis, through the “Tender Offer” route at a price of Rs 670 (Rupees Six Hundred And Seventy Only) per equity share for an aggregate maximum amount of Rs 231,15,00,000 (Rupees Two Hundred And Thirty One Crores Fifteen Lakhs Only) from January 04,2018 to January 17,2018.
| NOVARTIS INDIA LTD - Buyback |
| Scripname |
NOVARTIS INDIA LTD |
| Security Type |
Equity |
| Symbol |
NOVARTIND |
| Issue Type |
Buyback - Tender Offer |
| Issue Period |
04 Jan 2018 to 17 Jan 2018 |
| Tick Price |
0.05 |
| Market Lot |
1 |
| Book Size – No. of Shares |
34,50,000 |
| Minimum Offer Quantity |
1 |
| Maximum Offer Quantity |
34,50,500 |
| Face Value |
5 |
| Floor Price/Offer Price |
670 |
| Name of Acquirer(s)/Company |
Novartis India Limited |
| Buyer Member |
Ambit Capital Private Ltd |
| Book Running Lead Manager |
Ambit Capital Private Ltd |
| Registrar |
LINK INTIME INDIA PRIVATE LIMITED |
HSL Mobile App 
